Citation Impact
Citing Papers
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Selexipag for the Treatment of Pulmonary Arterial Hypertension
2015
The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear Cells
1989 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Endothelium‐independent relaxation of rabbit coronary artery by 17β‐oestradiol in vitro
1991
Systemic sclerosis
2017 Standout
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
2003
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Coxibs and Cardiovascular Disease
2004 Standout
The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease
1994 Standout
Prostaglandins, bioassay and inflammation
2006
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
1992 Standout
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Inhibition of NF-κB by Sodium Salicylate and Aspirin
1994 StandoutScience
Vascular endothelial cells synthesize nitric oxide from L-arginine
1988 StandoutNature
Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
1969 StandoutNatureNobel
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
1992 StandoutNobel
Role of dietary factors in the progression of chronic renal disease
1983
Indomethacin-Induced Prostaglandin Inhibition with Hyperkalemia
1979
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat
1987
Modes of action of aspirin-like drugs.
1985
Inactivation of Prostaglandins by the Lungs
1970 StandoutNatureNobel
Bioassay of prostacyclin and endothelium‐derived relaxing factor (EDRF) from porcine aortic endothelial cells
1986
Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans.
1985
Cyclo-oxygenase products in carrageenin-induced inflammation
1979
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Compensatory Prostaglandin E2 Biosynthesis in Cyclooxygenase 1 or 2 Null Cells
1998
Regulation of adrenergic receptor function by phosphorylation. I. Agonist-promoted desensitization and phosphorylation of alpha 1-adrenergic receptors coupled to inositol phospholipid metabolism in DDT1 MF-2 smooth muscle cells.
1987 StandoutNobel
Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism
1976 StandoutNatureNobel
Adventures and Excursions in Bioassay: The Stepping Stones to Prostacyclin (Noble Lecture)
1983 Nobel
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
1977 StandoutNobel
Limb ischemia preconditions the heart against reperfusion tachyarrhythmia
1997
[30] Microsomal lipid peroxidation
1978 Standout
Free Radical Mechanisms in Tissue Injury
1988
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
A genome-wide analysis of immune responses in Drosophila
2001 StandoutNobel
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
1978 StandoutNobel
Aspirin and Other Platelet-Active Drugs
1992
The effect of dietary supplementation of fish oil on experimental myocardial infarction
1980
Participation of renal cortical prostaglandins in the regulation of glomerular filtration rate
1981
Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil Function
1985 StandoutNobel
PROSTACYCLIN ADMINISTRATION DURING CARDIOPULMONARY BYPASS IN MAN
1981
Some Properties of Angiotensin Converting Enzyme in the Lung in vivo
1970 StandoutNatureNobel
The protective effects of dietary fish oil on focal cerebral infarction
1979
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
1983
Prostacyclin is a circulating hormone
1978 StandoutNatureNobel
EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN
1982
The role of endotoxin in protection of adult rats from oxygen-induced lung toxicity.
1978 StandoutNobel
Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid
1979
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
1984 StandoutNobel
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
1980 StandoutNatureNobel
Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.
1983 StandoutNobel
Autoregulation of bradykinin receptors and bradykinin-induced prostacyclin formation in human fibroblasts.
1984
The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system
1990
Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig
1975
RAPID REDUCTION OF PROSTAGLANDIN 15‐HYDROXY DEHYDROGENASE ACTIVITY IN RAT TISSUES AFTER TREATMENT WITH PROTEIN SYNTHESIS INHIBITORS
1975 StandoutNobel
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
1987 Standout
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
1984 Standout
Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.
1982 Standout
Mediators produced by the endothelial cell.
1988 Nobel
The mode of action of aspirin and similar compounds
1976 StandoutNobel
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Profile of Circulating Vasoactive Substances in Hemorrhagic Shock and Their Pharmacologic Manipulation
1974
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
1986 StandoutNature
Release of renal prostaglandins during endotoxin-induced hypotension
1976 StandoutNobel
Biological Sciences: Blood Concentration of Noradrenaline in the Dog after Intravenous Administration and the Effects of Desipramine
1971 StandoutNatureNobel
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
1985 Standout
Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids
1976 StandoutNatureNobel
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice.
1981
PROSTACYCLIN (PGI2) INHIBITS THE FORMATION OF PLATELET THROMBI IN ARTERIOLES AND VENULES OF THE HAMSTER CHEEK POUCH
1978 StandoutNobel
The release and fate of vaso‐active hormones in the circulation
1969 StandoutNobel
Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice
2012
Endotoxin and prevention of hypoxic pulmonary vasoconstriction.
1976
The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenin-induced inflammation
1980 StandoutNobel
Bioassay of prostacyclin and endothelium‐derived relaxing factor (EDRF) from porcine aortic endothelial cells
1997
NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein.
1990 StandoutNobel
Works of Vane being referenced
Prostacyclin and the vascular endothelium.
1981
Prostacyclin in physiology and pathophysiology.
1982
The role of prostacyclin in vascular tissue.
1979
Prostacyclin reduces the number of 'slow moving' leucocytes in hamster cheek pouch venules [proceedings].
1978
Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.
1982
Regulatory mechanisms of the vascular endothelium: an update.
1995
Prostacyclin (PGI2) inhibits the formation of platelet thrombi induced by adenosine diphosphate (ADP) in vivo [proceedings].
1977
Prostacyclin and its clinical applications.
1984
Mediators of the anaphylactic reaction.
1971
Further experiments to establish that the analgesic action of aspirin-like drugs depends on the inhibition of prostaglandin biosynthesis.
1973
Inhibitors of prostaglandin, prostacyclin, and thromboxane synthesis.
1978
Prostaglandins as mediators of inflammation.
1976
The assay of catecholamines released into the circulation of the guinea-pig by angiotensin.
1967
Prostacyclin is produced in whole blood [proceedings].
1978
Prostaglandins and the regulation of blood pressure.
1975
Factors influencing the turnover of prostaglandin synthetase.
1975
Bioassay of prostaglandins and biologically active substances derived from arachidonic acid.
1978
Appearance of prostaglandins in the renal venous blood of dogs in response to acute systemic hypotension produced by bleeding or endotoxin.
1973
Relative potency of prostacyclin, prostaglandin E1 and D2 as inhibitors of platelet aggregation in several species [proceedings].
1977
Prostacyclin as a potent dilator of arterioles in the hamster cheek pouch [proceedings].
1978
Prostacyclin production by rabbit aorta, pericardium, pleura, peritoneum and dura mater.
1978
Prostacyclin-release by bradykinin in vivo [proceedings].
1979
On the mechanism of the release of prostaglandins E2 and F2 alpha in renal venous blood during endotoxin-hypotension.
1974
The effects of antiinflammatory drugs on the production of prostaglandins in vivo.
1976